199 related articles for article (PubMed ID: 33522320)
1. Exploration of novel heterofused 1,2,4-triazine derivative in colorectal cancer.
Hermanowicz JM; Szymanowska A; Sieklucka B; Czarnomysy R; Pawlak K; Bielawska A; Bielawski K; Kalafut J; Przybyszewska A; Surazynski A; Rivero-Muller A; Mojzych M; Pawlak D
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):535-548. PubMed ID: 33522320
[TBL] [Abstract][Full Text] [Related]
2. The activity of pyrazolo[4,3-
Szymanowska A; Radomska D; Czarnomysy R; Mojzych M; Kotwica-Mojzych K; Bielawski K; Bielawska A
J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2343352. PubMed ID: 38700244
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel 1,3,5-triazine derivatives as potent inhibitor of cervical cancer via dual inhibition of PI3K/mTOR.
Hu J; Zhang Y; Tang N; Lu Y; Guo P; Huang Z
Bioorg Med Chem; 2021 Feb; 32():115997. PubMed ID: 33440319
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of mono-and di-pyrazolyl-s-triazine derivatives, their anticancer profile in human cancer cell lines, and in vivo toxicity in zebrafish embryos.
Farooq M; Sharma A; Almarhoon Z; Al-Dhfyan A; El-Faham A; Taha NA; Wadaan MAM; Torre BG; Albericio F
Bioorg Chem; 2019 Jun; 87():457-464. PubMed ID: 30927586
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Structure and Antiproliferative Activity of New pyrazolo[4,3- e]triazolo[4,5-b][1,2,4]triazine Derivatives.
Mojzych M; Tarasiuk P; Karczmarzyk Z; Juszczak M; Rzeski W; Fruzinski A; Wozny A
Med Chem; 2018; 14(1):53-59. PubMed ID: 29065838
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Novel 7-methyl-5-phenyl-pyrazolo[4,3-
Gornowicz A; Szymanowska A; Mojzych M; Bielawski K; Bielawska A
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32717981
[TBL] [Abstract][Full Text] [Related]
7. Review of the Synthesis and Anticancer Properties of Pyrazolo[4,3-
Bernat Z; Szymanowska A; Kciuk M; Kotwica-Mojzych K; Mojzych M
Molecules; 2020 Aug; 25(17):. PubMed ID: 32872493
[TBL] [Abstract][Full Text] [Related]
8. The Antiproliferative and Apoptotic Effect of a Novel Synthesized
Malebari AM; Abd Alhameed R; Almarhoon Z; Farooq M; Wadaan MAM; Sharma A; de la Torre BG; Albericio F; El-Faham A
Molecules; 2021 Feb; 26(4):. PubMed ID: 33671801
[TBL] [Abstract][Full Text] [Related]
9. ASR352, A potent anticancer agent: Synthesis, preliminary SAR, and biological activities against colorectal cancer bulk, 5-fluorouracil/oxaliplatin resistant and stem cells.
Narayan S; Ramisetti S; Jaiswal AS; Law BK; Singh-Pillay A; Singh P; Amin S; Sharma AK
Eur J Med Chem; 2019 Jan; 161():456-467. PubMed ID: 30384048
[TBL] [Abstract][Full Text] [Related]
10. Chrysophanol exhibits inhibitory activities against colorectal cancer by targeting decorin.
Deng M; Xue Y; Xu L; Wang Q; Wei J; Ke X; Wang J; Chen X
Cell Biochem Funct; 2020 Jan; 38(1):47-57. PubMed ID: 31710116
[TBL] [Abstract][Full Text] [Related]
11. Palladium (II) Complex Enhances ROS-Dependent Apoptotic Effects via Autophagy Inhibition and Disruption of Multiple Signaling Pathways in Colorectal Cancer Cells.
Aydinlik S; Erkisa M; Ari F; Celikler S; Ulukaya E
Anticancer Agents Med Chem; 2021; 21(10):1284-1291. PubMed ID: 32990544
[TBL] [Abstract][Full Text] [Related]
12. 1,3,5-Triazine-azole Hybrids and their Anticancer Activity.
Guo H; Diao QP
Curr Top Med Chem; 2020; 20(16):1481-1492. PubMed ID: 32156236
[TBL] [Abstract][Full Text] [Related]
13. The Anticancer Action of a Novel 1,2,4-Triazine Sulfonamide Derivative in Colon Cancer Cells.
Gornowicz A; Szymanowska A; Mojzych M; Czarnomysy R; Bielawski K; Bielawska A
Molecules; 2021 Apr; 26(7):. PubMed ID: 33918514
[TBL] [Abstract][Full Text] [Related]
14. A novel microtubule destabilizing entity from orthogonal synthesis of triazine library and zebrafish embryo screening.
Moon HS; Jacobson EM; Khersonsky SM; Luzung MR; Walsh DP; Xiong W; Lee JW; Parikh PB; Lam JC; Kang TW; Rosania GR; Schier AF; Chang YT
J Am Chem Soc; 2002 Oct; 124(39):11608-9. PubMed ID: 12296721
[TBL] [Abstract][Full Text] [Related]
15. Di- and tri-substituted s-triazine derivatives: Synthesis, characterization, anticancer activity in human breast-cancer cell lines, and developmental toxicity in zebrafish embryos.
El-Faham A; Farooq M; Almarhoon Z; Alhameed RA; Wadaan MAM; de la Torre BG; Albericio F
Bioorg Chem; 2020 Jan; 94():103397. PubMed ID: 31706684
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, antitumor evaluation and microarray study of some new pyrazolo[3,4-d][1,2,3]triazine derivatives.
Nasr T; Bondock S; Youns M; Fayad W; Zaghary W
Eur J Med Chem; 2017 Dec; 141():603-614. PubMed ID: 29107422
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of sphingosine-1-phosphate receptor 2 antagonists as potent 5-FU-resistance reversal agents for the treatment of colorectal cancer.
Luo D; Zhang Y; Yang S; Tian X; Lv Y; Guo Z; Liu X; Han G; Liu S; Wang W; Cui S; Qu X; Wan S
Eur J Med Chem; 2021 Dec; 225():113775. PubMed ID: 34411894
[TBL] [Abstract][Full Text] [Related]
18. Novel cinnamaldehyde-based aspirin derivatives for the treatment of colorectal cancer.
Lu S; Obianom ON; Ai Y
Bioorg Med Chem Lett; 2018 Sep; 28(17):2869-2874. PubMed ID: 30037494
[TBL] [Abstract][Full Text] [Related]
19. Isobavachalcone isolated from
Li Y; Qin X; Li P; Zhang H; Lin T; Miao Z; Ma S
Drug Des Devel Ther; 2019; 13():1449-1460. PubMed ID: 31118579
[No Abstract] [Full Text] [Related]
20. Development of EGFR-targeted evodiamine nanoparticles for the treatment of colorectal cancer.
Li C; Cai G; Song D; Gao R; Teng P; Zhou L; Ji Q; Sui H; Cai J; Li Q; Wang Y
Biomater Sci; 2019 Aug; 7(9):3627-3639. PubMed ID: 31328737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
